Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes

Area of Science:

• Genetics
• Metabolic Disorders
• Ophthalmology
• Nephrology

Background:

• Diabetes complications like retinopathy and nephropathy are not fully explained by duration or glycemic control.
• Genetic factors likely play a role in the varying susceptibility to these microvascular complications.
• Thiamine is crucial for glucose metabolism and mitigating high glucose damage.

Purpose of the Study:

• To investigate the association between genetic variants in thiamine transporters and the risk of severe diabetic retinopathy and nephropathy.
• To identify specific genes and polymorphisms that may influence the development of these diabetes complications.

Main Methods:

• Tested 134 single nucleotide polymorphisms (SNPs) in thiamine transporters (SLC19A2/3) and their transcription factors (SP1/2).
• Analyzed associations in the FinnDiane cohort, with replication in DCCT/EDIC and WESDR cohorts.
• Conducted a meta-analysis including the WESDR cohort for genome-wide significance.

Main Results:

• Two SNPs in the SLC19A3 locus showed association with reduced rates of severe retinopathy.
• These SNPs were also linked to a combined phenotype of severe retinopathy and end-stage renal disease.
• The association for the combined phenotype achieved genome-wide significance in the meta-analysis.

Conclusions:

• Genetic variations in SLC19A3 are implicated in the pathogenesis of severe diabetic retinopathy and nephropathy.
• These genetic factors may contribute to explaining why some individuals with type 1 diabetes are more protected against microvascular complications.